Title of article :
Chronic Treatment with Mood Stabilizers Increases Membrane GRK3 in Rat Frontal Cortex
Author/Authors :
Renee N. Ertley، نويسنده , , Richard P. Bazinet، نويسنده , , Ho-Joo Lee، نويسنده , , Stanley I. Rapoport، نويسنده , , Jagadeesh S. Rao، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Abstract :
Background
G-protein receptor kinases (GRKs) are a family of serine/threonine kinases involved in the homologous desensitization of agonist activated G-protein coupled receptors (GPCRs). G-protein coupled receptor supersensitivity, possibly as a result of decreased GRK, has been suggested in affective disorders.
Methods
We used immunobloting to determine if chronic, therapeutically relevant doses of lithium (Li+), carbamazepine (CBZ), and valproate (VPA), would increase GRK2/3 protein levels in rat frontal cortex.
Results
Chronic Li+ (24%) and CBZ (44%) significantly increased GRK3 in the membrane but not cytosol fractions. Chronic VPA had no effect on GRK3. G-protein receptor kinase 2 protein levels were unchanged by all treatments. The GRK3 membrane to cytosol ratio was increased significantly in Li+ and CBZ treated rats.
Conclusions
These results show that chronically administered Li+ and CBZ, but not VPA, increase the translocation of GRK3 from cytosol to membrane, possibly correcting supersensitivity of GPCRs in bipolar disorder.
Keywords :
GRK3 , GRK2 , lithium , carbamazepine , valproate , brain
Journal title :
Biological Psychiatry
Journal title :
Biological Psychiatry